Clinical Trials Browser

Phase 1/2 × OTHER × zanubrutinib × Clear all

NCT07052695 2025-12-15

Mosunetuzumab for CLL MRD Clearance

Phase 1/2 Recruiting

LymphoidOther hematologic neoplasm

Leukemia, Lymphoma, Leukemia, Lymphocytic, Chronic, B-Cell

NCT06029309 2025-10-06

ZANU-TAFA

Phase 1/2 Recruiting

Lymphoma, Mantle-Cell